{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"25"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"25"}],"units":"Participants"}],"description":"To assess GI symptoms using Patient Reported Outcomes within the Common Terminology Criteria for Adverse Events","groups":[{"description":"Individuals with Myeloma on lenalidomide maintenance who experience grade 2 or more diarrhea","id":"OG000","title":"Participants With Myeloma"}],"paramType":"COUNT_OF_PARTICIPANTS","reportingStatus":"POSTED","timeFrame":"4 weeks","title":"Number of Participants With GI Symptom Assessment","type":"SECONDARY","unitOfMeasure":"Participants"}